BC patients who experienced positive clinical outcomes demonstrated a greater infiltration of cytotoxic CD8+ T cells that were positive for granzyme B. This finding suggests a more robust and active immune response within the tumor microenvironment of these patients. The gene discussed is CD8A; the disease is neoplasm.